Acute drug transfer and particle release of drug coated balloons within a porcine in-vitro model
Drug coated balloons (DCB) are used in the therapy of coronary as well as peripheral artery disease. The success of drug transfer to the vessel wall depends on the excipient used in combination with paclitaxel as antiproliferative drug. Although in-vivo studies show very good results with this techn...
Main Authors: | Brandt-Wunderlich Christoph, Almstädt Lucas, Kaule Sebastian, Reske Thomas, Schmidt Wolfram, Schmitz Klaus-Peter, Grabow Niels |
---|---|
Format: | Article |
Language: | English |
Published: |
De Gruyter
2017-09-01
|
Series: | Current Directions in Biomedical Engineering |
Subjects: | |
Online Access: | https://doi.org/10.1515/cdbme-2017-0098 |
Similar Items
-
Comparison of Effectiveness of Drug-Coated Balloon Angioplasty versus Plain Balloon Angioplasty in Chronic Lower Extremity Ischemia Patients
by: Nazari I, et al.
Published: (2020-09-01) -
Pre-Clinical Investigation of Keratose as an Excipient of Drug Coated Balloons
by: Emily Goel, et al.
Published: (2020-03-01) -
Development and in Vitro Characterization of Photochemically Crosslinked Polyvinylpyrrolidone Coatings for Drug-Coated Balloons
by: Svea Petersen, et al.
Published: (2013-12-01) -
Cutaneous polyarteritis nodosa resulting from a paclitaxel-eluting balloon angioplasty
by: Allison Montgomery, BA, et al.
Published: (2018-01-01) -
New developments in the clinical use of drug-coated balloon catheters in peripheral arterial disease
by: Naghi J, et al.
Published: (2016-06-01)